Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.9%

1 terminated/withdrawn out of 17 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

N/A
4(33.3%)
Phase 2
4(33.3%)
Phase 1
3(25.0%)
Phase 3
1(8.3%)
12Total
N/A(4)
Phase 2(4)
Phase 1(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT02316457Phase 1Completed

RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID

Role: collaborator

NCT05522374Recruiting

TIRCON International NBIA Registry

Role: collaborator

NCT01818492Phase 2Completed

Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis

Role: collaborator

NCT02069899Phase 2Completed

A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody

Role: collaborator

NCT02841501Completed

Genetic Susceptibility Factors for Candidemia.

Role: collaborator

NCT02962908Phase 2Completed

A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine

Role: collaborator

NCT02622724Phase 3Terminated

Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS)

Role: collaborator

NCT02373566Not ApplicableCompleted

A Study to Evaluate the Efficacy of an Acellular Dermal Template for the Treatment of Full Thickness Skin Defects

Role: collaborator

NCT02164760Not ApplicableCompleted

The Safety of a Novel Acellular Dermal Template as Treatment for Burns and Scars

Role: collaborator

NCT03147352Completed

Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study

Role: collaborator

NCT02244801Phase 1Completed

Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )

Role: collaborator

NCT02141607Completed

Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock

Role: collaborator

NCT02691130Phase 2Completed

Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults

Role: collaborator

NCT02631629Not ApplicableCompleted

Food-based Solutions for Optimal Vitamin D Nutrition and Health

Role: collaborator

NCT02180906Completed

Biomarkers in Patients With Flesh-eating Bacterial Infections

Role: collaborator

NCT01485952Phase 1Completed

An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196

Role: collaborator

NCT00267540Not ApplicableCompleted

The Effect of Vitamin D on Bone Accretion and Turn-Over in Young Girls

Role: collaborator

All 17 trials loaded